PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

MINNEAPOLIS, MN, Jan. 23, 2024 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ:PETV & PETVW) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application related to the Company’s proprietary biomaterials and corresponding products. The broad scope of the issued claims in this patent, entitled “Protein Biomaterials and Biocoacervates and Methods of Making and Using Thereof” provides protection for a broad range of proprietary products, including the biocompatible sponge-like particles used in PetVivo’s signature product, Spryng^™ with OsteoCushion^™ Technology.

Read more at globenewswire.com